Tratamento farmacológico da doença de Alzheimer

by Forlenza,Orestes V.
Published 2005

Ginkgo biloba e memória: mito ou realidade?

by Forlenza,Orestes V.
Published 2003

Transtornos depressivos na doença de Alzheimer: diagnóstico e tratamento

by Forlenza,Orestes V
Published 2000

Delirium: uma perspectiva histórica

by Wacker,Priscilla, Nunes,Paula V., Forlenza,Orestes V.
Published 2005

Delirium e demência no idoso: existem fatores de risco comuns?

by Wacker,Priscilla, Nunes,Paula V., Forlenza,Orestes V.
Published 2005

Lítio e neuroproteção: novos usos potenciais em psiquiatria

by Nunes,Paula V., Forlenza,Orestes V., Gattaz,Wagner F.
Published 2007

Cognitive impairment: an (in)dependent risk factor for mortality in older men?

by Loureiro,Júlia C., Pais,Marcos V., Forlenza,Orestes V.
Published 2020

Redução dos níveis séricos de ácido fólico em pacientes com a doença de Alzheimer

by Almeida,Cesar C., Brentani,Helena P., Forlenza,Orestes V., Diniz,Breno S.
Published 2012

Papel da proteína Tau na fisiopatologia da demência frontotemporal

by Paula,Vanessa J. R. de, Guimarães,Fabiana M., Forlenza,Orestes V.
Published 2009

Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly

by Ladeira,Rodolfo B., Diniz,Breno S., Nunes,Paula V., Forlenza,Orestes V.
Published 2009

Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease

by Forlenza,Orestes V., Diniz,Breno S., Teixeira,Antonio L., Stella,Florindo, Gattaz,Wagner
Published 2013

Increased CSF levels of total Tau in patients with subcortical cerebrovascular pathology and cognitive impairment

by Radanovic,Márcia, Stella,Florindo, Silva,Lis Gomes, Talib,Leda L., Forlenza,Orestes V.
Published 2017

Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia

by Forlenza,Orestes V., Diniz,Breno S., Stella,Florindo, Teixeira,Antonio L., Gattaz,Wagner F.
Published 2013

Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort

by Radanovic,Márcia, Oshiro,Carlos A., Freitas,Thiago Q., Talib,Leda L., Forlenza,Orestes V.
Published 2019

Anti-amyloid agents for treating incipient Alzheimer’s disease: a new hope?

by Loureiro,Julia C., Silva,Luiz Fernando A.L., Pais,Marcos V., Forlenza,Orestes V.
Published 2022

Quality of life and Alzheimer's disease: Influence of participation at a rehabilitation center

by Machado,Fernanda, Nunes,Paula V., Viola,Luciane F., Santos,Franklin S., Forlenza,Orestes V., Yassuda,Mônica S.
Published 2009

Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer’s disease patients

by JOAQUIM,HELENA P. G., COSTA,ALANA C., FORLENZA,ORESTES V., GATTAZ,WAGNER F., TALIB,LEDA L.
Published 2019

Tratamento da doença de Alzheimer: recomendações e sugestões do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia

by Engelhardt,Eliasz, Brucki,Sonia M.T., Cavalcanti,José Luiz S., Forlenza,Orestes V., Laks,Jerson, Vale,Francisco A.C.
Published 2005

Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment

by Forlenza,Orestes V., Diniz,Breno S., Talib,Leda L., Radanovic,Marcia, Yassuda,Monica S., Ojopi,Elida B., Gattaz,Wagner F.
Published 2010

Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review

by Stella,Florindo, Valiengo,Leandro C. Lane, Paula,Vanessa J. R. de, Lima,Carlos Augusto de Mendonça, Forlenza,Orestes V.
Published 2021